Bing

SEARCH HISTORY

Perrigo (PRGO), a U.S. generic drug company that is domiciled in Ireland for tax purposes, may also be a takeover target according to Israeli business paper Globes. The stock was up almost 8.7% to top the S&P 500 Monday. Related: Higher price tag no ...
CNN Money · 7/14/2014
High Dividend Yield Stocks Close To New Highs By Dividend Yield – Stock ... The beta ratio is 0.73. Perrigo Company (PRGO) has a market capitalization of $10.24 billion. The company employs 8,700 people, generates revenues of $2,755.03 million and ...
Guru Focus · 6/13/2012
When the merger is completed, the investor will exchange the stock of the company being acquired for the deal consideration. In this case, Mylan (MYL) is offering Perrigo (PRGO) a headline number of $205 a share, which is comprised of $60 in cash plus 2.
Market Realist · 4/29/2015
PRGO) for $205 per share, or $28.86 billion. Mylan’s cash-and-stock offer comes at a premium of 24 percent to the latest closing price for Perrigo shares, according to the Associated Press. The combined company will be a juggernaut in generic and ...
ETF Trends Setting The Pace · 4/8/2015
Teva Pharmaceutical Industries (>> Teva Pharmaceutical Industries Limited) has agreed to buy Allergan Plc's (>> Allergan, Inc.) generic drugs business for $40.5 billion (26.10 billion pounds) in a cash and stock deal that will turn the Israeli company into ...
4 Traders · 7/27/2015
CHICAGO, April 9, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INO, PRGO, WB, RGLS and QIHU. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by …
Market Watch · 4/9/2015
The cash and stock deal gives Amag access to Lumara's Makena, the only approved product designed ... said it would sell to Perrigo Co Plc (PRGO.N) for $82 million in cash. Analysts said Makena's addition to Amag sales channel works well with the …
Reuters · 9/29/2014
One of the main worries of Tel Aviv Stock Exchange (TASE) leaders recently has been the expected delisting of Perrigo Company (NYSE:PRGO; TASE:PRGO), if and when the company's acquisition by Mylan Pharmaceuticals is completed. Perrigo has …
globes.co.il · 6/18/2015
Perrigo Co. (PRGO) experienced unusually high volume on Jun. 16, as the stock gained 4.34% to a closing price of $191.25. The stock saw 2.24 million shares trade hands over the course of the day on 19,190 trades. Given that the stock’s average daily ...
Equities · 6/16/2015
Generic drugmaker Mylan NV (MYL.O) has offered to buy Perrigo Co Plc (PRGO.N) for about $29 billion (19.5 billion pounds) in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic …
Reuters · ByBill Berkrot · 4/8/2015

Perrigo

Perrigo Company plc is an Irish international manufacturer of private label over-the-counter pharmaceuticals. The company’s shares are tra…
Perrigo Company plc is an Irish international manufacturer of private label over-the-counter pharmaceuticals. The company’s shares are traded on the NYSE and the Tel Aviv Stock Exchange; as a result of the merger with Agis Industries the company is a constituent of the TA-25 Index. Perrigo is the only non-Israeli company on the TA-25.
Data from: Wikipedia